Clinical Trial

Uromodulin as a Biomarker in Lupus Nephritis

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Evaluation of Uromodulin as a biomarker of renal histological activity/ Chronicity indices in lupus nephritis
Trial Details
NCT Number NCT07763834
Lead Sponsor Assiut University
Conditions Uromodulin, SLE
Enrollment 90 participants
Start Date 2026-10-01
Primary Completion 2029-08-02 (estimated)
Study Completion 2030-03-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-13